Europe Cleanroom Technology Market Analysis with Key Players and Forecast Report 2023

The Europe cleanroom technology market is forecasted to generate $1,701.8 million revenue by 2023. The market is mainly driven by increasing number of conferences, seminars, and events for cleanroom technology, growing infectious diseases, and increasing healthcare expenditure in the region.

Request for report sample at: https://www.psmarketresearch.com/market-analysis/europe-cleanroom-technology-market/report-sample

The different types of products available in the European cleanroom technology market are cleanroom consumables and equipment. The market for cleanroom consumables is expected to observe faster growth, witnessing a CAGR of more than 7.0% during the forecast period. The growth is mainly driven by the increasing adoption of these products to maintain aseptic environment in various industries, such as pharmaceutical, biotechnology, and medical devices; hospitals; and research laboratories.

On the basis of construction, the European cleanroom technology market is categorized into standard, hardwall, softwall, and pass-through cleanrooms. Hardwall cleanrooms is expected to be the fastest growing category in this market, exhibiting a CAGR of more than 7.5% during the forecast period. This growth is mainly due to increasing research and development (R&D) of pharmaceuticals in the region, which involves the use of hardwall cleanrooms, specifically designed for research activities.

Pharmaceutical, biotechnology, and medical devices industries generate huge demand for cleanroom technology products. Various pharmaceutical and biotechnology products, such as vaccines, injections, biologics, and ointments, need to be prepared in an environment that is free from microbes and particulates. Cleanroom offers suitable environmental conditions by lowering the level of pollutants, such as dust, chemical vapors, microbes, and aerosol particles.

Some of the other players in the European cleanroom technology industry include M+W Group GmbH, Ardmac Ltd., Alpiq Holding Ltd., cleanroom.de GmbH, OCTANORM-Vertriebs-GmbH, MonMouth Scientific Ltd., Cleanroom Systems Belgium, Parteco Srl, Mach-Aire Ltd., E.I. du Pont de Nemours and Company, Kimberly-Clark Corporation, Taikisha Ltd., and Illinois Tool Works Inc.

Source: P&S Intelligence

Animal Vaccines Market and its Growth Landscape for the Next Few Years

Vaccines have proven to be a boon for animal health in veterinary medicine. With increase in the number of adoption cases of companion animals globally, vaccination has become important for these animals as they suffer from various diseases. Strong focus on the development of needle-free DNA animal vaccines and ongoing research on plant-based animal vaccines have added to the growth of the market.

Get report sample at: https://www.psmarketresearch.com/market-analysis/animal-vaccines-market/report-sample

Other than this, growth in livestock population and repeated outbreaks of life-stock diseases; rising incidence of zootonic diseases; introduction of new vaccines; and government initiatives by various agencies, animal associations, and major market players are also boosting the growth of the global animal vaccines market.

Geographically, North America is expected to lead the global animal vaccines market in the coming years, owing to the stringent regulations for vaccines production, increasing awareness against the use of antimicrobials, and rising number of innovations in developing vaccines for animals in the region.

Various factors, including, rising technological innovations and introduction of innovative vaccines; such as DNA, and recombinant vaccines; improved healthcare facilities; and growing investment by government bodies are positively impacting the growth of this market. Recombinant vaccines represent an innovative option to overcome the limitations of conventional vaccines, since these can be produced efficiently in large amounts and usually present low reactogenicity and toxicity.

Browse full report at: https://www.psmarketresearch.com/market-analysis/animal-vaccines-market

Ongoing partnerships and product approvals in the industry are expected to increase the market share of the players in the coming years. For instance, in September 2018, U.S. Department of Agriculture (USDA) granted an expanded indication to Cytopoint, a novel monoclonal antibody (mAb) therapy by Zoetis Inc., for the treatment of allergic dermatitis in dogs. Cytopoint is the first mAb therapy licensed to treat allergic as well as atopic dermatitis, an indication for which it was fully licensed by the USDA in 2016.

Other than Zoetis Inc, the animal vaccines industry is marked by the presence of market players, such as Merck & Co. Inc., C.H. Boehringer Sohn AG & Ko. KG, Eli Lilly and Company, Ceva Santé Animale S.A., Virbac Group, Bayer AG, Vetoquinol S.A., Phibro Animal Health Corporation, and Hester Biosciences Limited.

Source: P&S Intelligence

High-Throughput Screening Market Rising Growth and Future Analysis

The global high-throughput screening market is witnessing considerable growth due to increasing geriatric population, increasing healthcare expenditure, increasing research and development activities, launch of technologically advanced products that are miniaturized and automated and growing popularity of high-throughput screening for drug discovery. Moreover, high adoption of high-throughput screening models in pharmaceutical and biotechnology companies across the globe is supporting the growth of the market. Based on technology, 2D cell culture segment is expected to grow at the fastest rate during the forecast period owing to its low cost and ease of use.

Request for report sample at: https://www.psmarketresearch.com/market-analysis/high-throughput-screening-market/report-sample

The rapid growth in emerging economies and growing research and development activities on stem cells and toxicology is expected to create opportunities for the manufacturers of high-throughput screening products. However, high cost of high-throughput screening, lack of trained professionals and complexity in assay development are the key factors hampering the growth of the global market.

High-throughput screening is a method that uses automation and large dataset processing to quickly assay the biological activity of large numbers of compounds, proteins and genes. High-throughput screening is used for drug discovery, target identification, biochemical screening, protein stabilization, and cell and organismal-based screening. It helps in optimizing substrate concentration, protein concentration and identification of physiologically relevant controls.

Browse full report at: https://www.psmarketresearch.com/market-analysis/high-throughput-screening-market

Geographically, North America has been the largest market for high-throughput screening, owing to its increased awareness, increasing government funding, established healthcare industry, and easy accessibility to advanced technologies due to the awareness in the region. The U.S. contributed largest revenue to the North American as well as global high-throughput screening market. The increased research and development activities and increasing prevalence of chronic diseases arising the need for novel treatments is the key growth driving factor for the U.S. high-throughput screening market.

The key players operating in the global market are Agilent Technologies, Inc, Danaher Corporation, Thermo Fisher Scientific Inc., Merck Millipore, Bio-Rad Laboratories, Inc., Hamilton Company and Aurora Biomed, Inc.

Source: P&S Intelligence

Protein Assay Market - New Business Opportunities & Investment Research Report 2024

Protein assays are utilized in life science research to detect the presence of protein in a sample. Estimation of protein fixation is important for protein cleaning, electrophoresis, cell science, atomic science, and research applications. Although there are a wide variety of protein assays available, none of the assays can be used without first considering their suitability for an application. Each assay has its own advantages and limitations and often it is necessary to obtain more than one type of assay for various research applications. The global protein assay market is expected to witness considerable growth during the forecast period (2017 – 2023), mainly due to the increasing investment by pharma and biotech companies in research and development (R&D), as well as funding by governments of various countries for proteomics research.

Get report sample at: https://www.psmarketresearch.com/market-analysis/protein-assay-market/report-sample

The global protein assay market is segmented on the basis of product, type, technology, application, end user and geography. Based on product, the global market is segmented into reagents, kits, and instruments and accessories. The reagents are expected to contribute the largest share in the global protein assay market.

The rising investment in pharmaceutical and biotechnology R&D, favorable government policies for proteomics research, and the presence of a large number of players in the global protein assay market are the key factors driving the growth of the market during the forecast period. According to a publication by Pharmaceuticals Research and Manufacturers of America (PhRMA), the member organizations (pharmaceutical companies) of PhRMA spent approximately $58.8 billion on R&D, accounting for the largest part of all the biopharmaceutical R&D spending in the U.S, in 2015. However, high cost of multiplex assay hardware is limiting the growth of global protein assay market.

North America was the largest market for protein assay in 2016, followed by Europe and Asia-Pacific. Asia-Pacific is expected to witness the highest growth during the forecast period. The growth in protein assay market in developing economies such as China, India, and Japan is primarily due to the increasing R&D expenditure in life science, and increase in the funding by various government and private organizations for proteomics research.

Browse full report at: https://www.psmarketresearch.com/market-analysis/protein-assay-market

The competition in the global protein assay market is very high, therefore, many players are concentrating on introducing various innovative approaches in this field.

In Feb 2017, Promega Corporation announced the development of a benchtop capillary electrophoresis (CE) instrument in collaboration with Hitachi High-Technologies Corporation. The Spectrum Compact CE system meets small batch and single sample requirements in DNA analysis and performs both sequencing and fragment analysis at a short notice. The Spectrum Compact CE System allows laboratories the freedom to carry NGS validation, PCR sizing and microsatellite analysis, single nucleotide polymorphism, de novo sequencing and mutation detection.

Some of the other key players operating in the global market are ThermoFisher Scientific, Inc., PerkinElmer, Inc., Bio-Rad Laboratories, Inc., Promega Corporation, GE Healthcare, Merck KGaA, Cell Signalling Technology, Inc., Abcam PLC, Lonza Group, BioVision Inc., Bio-Techne Corporation (Novus Biologicals) and G-Biosciences Inc.

Source: P&S Intelligence

Metabolomics Market to Grow at a Brisk rate in the Foreseeable Future

The global metabolomics market is projected to achieve a lucrative growth rate during the forecast period due to the increased government and private funding in research and development, and rise in metabolic application in personalized medication. The market is led by instruments, in terms of size, majorly attributable to the fact that metabolomics instrument is extensively used while following the various steps of the experimental protocol. Metabolomics bioinformatics tools and services are expected to witness the faster growth in future, as it facilitates simpler analysis and data interpretation of widely available biological data.

Request for report sample at: https://www.psmarketresearch.com/market-analysis/metabolomics-market/report-sample

Metabolomics has wide application in various field, these include biomarker discovery, drug discovery, toxicology testing, nutrigenomics, functional genomics, personalized medicine, and others. The biomarker discovery was the largest application area of metabolomics in 2016, due to to the rise in prevalence of chronic diseases on the global level. Additionally, the extensive oncological research with inclination towards study of new biomarkers and its cancer application drives the larger contribution of biomarker discovery in the market.

Various factors leading to the growth of the metabolomics industry include the rise in funding for technological research from government as well as private organizations, along with increase in collaborations & partnerships of key players for enhancement of their product portfolio. There has been significant rise in the R&D expenditure by the key players for development of technologically advanced metabolomics platforms, which is expected to drive the growth of the market during the forecast period. The advent of personalized medication also acts as a driving force to the growth of the market.

The key players have been focused in the enhancement of their product portfolio, by forming partnerships. to increase metabolomics market share.

For instance, in June 2017, Thermo Fisher Scientific Inc. (Thermo Fisher) and Biocrates Life Sciences AG announce the launch of a ready-to-use kit for accurate metabolic phenotyping on high resolution mass spectrometry instruments. Under the co-marketing agreement, both the companies will jointly promote and market the combined use of the kit and Thermo Fisher’s Q Exactive high-resolution, accurate-mass (HRAM) platform of mass spectrometers.

Browse full report at: https://www.psmarketresearch.com/market-analysis/metabolomics-market

Some of the other key players in the global market include Agilent Technologies, Inc., Danaher Corporation, Waters Corporation, Shimadzu Corporation, Bio-Rad Laboratories, Inc., Bruker Corporation, Human Metabolome Technologies Inc., Metabolon, Inc.

Source: P&S Intelligence